X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB MERCK LTD UNICHEM LAB/
MERCK LTD
 
P/E (TTM) x 32.8 34.2 96.0% View Chart
P/BV x 3.5 3.8 90.3% View Chart
Dividend Yield % 0.5 0.7 74.4%  

Financials

 UNICHEM LAB   MERCK LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
MERCK LTD
Dec-16
UNICHEM LAB/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs3341,060 31.5%   
Low Rs174623 27.9%   
Sales per share (Unadj.) Rs146.9632.4 23.2%  
Earnings per share (Unadj.) Rs11.945.7 26.0%  
Cash flow per share (Unadj.) Rs16.262.3 26.0%  
Dividends per share (Unadj.) Rs2.0011.00 18.2%  
Dividend yield (eoy) %0.81.3 60.2%  
Book value per share (Unadj.) Rs105.1388.8 27.0%  
Shares outstanding (eoy) m90.8416.60 547.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.3 129.9%   
Avg P/E ratio x21.418.4 116.0%  
P/CF ratio (eoy) x15.713.5 116.2%  
Price / Book Value ratio x2.42.2 111.7%  
Dividend payout %16.824.1 69.9%   
Avg Mkt Cap Rs m23,07313,969 165.2%   
No. of employees `0005.71.6 358.4%   
Total wages/salary Rs m2,5581,487 172.1%   
Avg. sales/employee Rs Th2,352.56,631.9 35.5%   
Avg. wages/employee Rs Th450.9939.2 48.0%   
Avg. net profit/employee Rs Th190.4479.4 39.7%   
INCOME DATA
Net Sales Rs m13,34610,498 127.1%  
Other income Rs m192242 79.2%   
Total revenues Rs m13,53810,741 126.0%   
Gross profit Rs m1,6391,135 144.4%  
Depreciation Rs m390276 141.6%   
Interest Rs m290-   
Profit before tax Rs m1,4121,102 128.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293343 85.3%   
Profit after tax Rs m1,080759 142.4%  
Gross profit margin %12.310.8 113.6%  
Effective tax rate %20.731.1 66.5%   
Net profit margin %8.17.2 112.0%  
BALANCE SHEET DATA
Current assets Rs m5,9796,410 93.3%   
Current liabilities Rs m2,4328,828 27.5%   
Net working cap to sales %26.6-23.0 -115.4%  
Current ratio x2.50.7 338.7%  
Inventory Days Days6358 109.3%  
Debtors Days Days6038 157.3%  
Net fixed assets Rs m6,4031,406 455.2%   
Share capital Rs m182166 109.5%   
"Free" reserves Rs m9,2936,286 147.8%   
Net worth Rs m9,5486,455 147.9%   
Long term debt Rs m2300-   
Total assets Rs m12,8438,828 145.5%  
Interest coverage x50.0NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.01.2 87.4%   
Return on assets %8.68.6 100.5%  
Return on equity %11.311.8 96.2%  
Return on capital %14.317.1 84.0%  
Exports to sales %29.28.3 352.8%   
Imports to sales %6.321.0 30.1%   
Exports (fob) Rs m3,900869 448.5%   
Imports (cif) Rs m8472,209 38.3%   
Fx inflow Rs m4,356959 454.4%   
Fx outflow Rs m1,1622,612 44.5%   
Net fx Rs m3,194-1,653 -193.2%   
CASH FLOW
From Operations Rs m1,1191,070 104.5%  
From Investments Rs m-853-750 113.8%  
From Financial Activity Rs m-334-150 223.1%  
Net Cashflow Rs m-68171 -40.0%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 15.1 18.2 83.0%  
FIIs % 3.0 1.0 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 29.1 108.9%  
Shareholders   20,176 28,591 70.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Market at Record Highs; Strong ITC & RIL Performance & Other Top Cues to Sway the Market Today(Pre-Open)

Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services. At the closing bell last week.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS